YN
Yigal Nochomovitz Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
61
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
80.6%
Neutral
17.7%
Negative
1.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $336 |
18%
upside
| 7 | +5.3% |
0
%
| 12 Jan ‘26 7 days ago |
|
|
|
Buy
Maintained
| $14 |
107%
upside
| 3 | +7.6% |
0
%
| 9 Jan ‘26 10 days ago |
|
|
|
Neutral
Maintained
| $4 |
14%
downside
| 1 | – |
–
| 6 Jan ‘26 13 days ago |
|
|
|
Neutral
Maintained
| $7 |
4%
downside
| 4 | +1.3% |
0
%
| 6 Jan ‘26 13 days ago |
|
|
|
Buy
Maintained
| $36 |
39%
upside
| 2 | +12% |
0
%
| 6 Jan ‘26 13 days ago |
|
|
|
Buy
Upgraded
| $15 |
23%
upside
| 3 | +9.2% |
0
%
| 6 Jan ‘26 13 days ago |
|
|
|
Buy
Maintained
| $60 |
121%
upside
| 2 | +288% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $7 |
2%
downside
| 1 | +68% |
0
%
| 10 Dec ‘25 1 month ago |
|
|
|
Buy
Initiated
| $270 |
40%
upside
| 1 | +4.5% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $16 |
32%
upside
| 1 | -1.1% |
0
%
| 17 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $24 |
275%
upside
| 2 | -8.6% |
0
%
| 14 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $77 |
44%
upside
| 2 | +4% |
0
%
| 12 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $31 |
49%
upside
| 2 | +9.6% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $6 |
326%
upside
| 3 | -7.2% |
0
%
| 10 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $405 |
20%
upside
| 1 | +5.7% |
0
%
| 10 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $14 |
156%
upside
| 2 | +8.5% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $8 |
448%
upside
| 1 | -40% |
0
%
| 3 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $45 |
126%
upside
| 4 | +3.9% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $56 |
157%
upside
| 2 | +23% |
0
%
| 29 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $203 |
53%
upside
| 2 | -2.9% |
0
%
| 29 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $46 |
128%
upside
| 1 | -37% |
0
%
| 28 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $40 |
135%
upside
| 2 | -7.6% |
0
%
| 20 Oct ‘25 3 months ago |
|
|
|
Neutral
Downgraded
| $97 | – | 1 | +54% |
–
| 29 Sep ‘25 3 months ago |
|
|
|
Buy
Maintained
| $69 |
271%
upside
| 1 | -47% |
0
%
| 11 Aug ‘25 5 months ago |
|
|
|
Buy
Maintained
| $22 |
6%
downside
| 2 | +47% |
0
%
| 11 Aug ‘25 5 months ago |
|